Document:

Careview Communications, Inc. 8-K

EXHIBIT
10.22 

 Execution
Copy

FIFTH
AMENDMENT TO

NOTE AND WARRANT PURCHASE AGREEMENT

This
FIFTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT, dated as of December 15, 2014 (this “Amendment”),
is made by and among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (the “Company”), and the investors
identified on Annex I attached hereto (together with their respective successors and permitted assigns, the “Investors”).

WITNESSETH:

WHEREAS,
the Company, HealthCor Partners Fund, L.P. (“HealthCor Partners”) and HealthCor Hybrid Offshore Master Fund,
L.P. (“HealthCor Hybrid” and, together with HealthCor Partners, the “HealthCor Parties”)
are parties to that certain Note and Warrant Purchase Agreement, dated as of April 21, 2011 (as amended from time to time, including
without limitation pursuant to that certain Note and Warrant Amendment Agreement dated December 20, 2011, that certain Second
Amendment to Note and Warrant Purchase Agreement dated January 31, 2012, that certain Third Amendment to Note and Warrant Purchase
Agreement dated August 20, 2013, and that certain Fourth Amendment to Note and Warrant Purchase Agreement dated January 16, 2014,
the “Purchase Agreement”); and

WHEREAS,
the Company issued and sold (a) $5,000,000 initial principal amount of additional Notes (as contemplated by the Purchase Agreement)
to the HealthCor Parties on January 31, 2012 and (b) $5,000,000 initial principal amount of additional Notes and additional Warrants
to purchase 4,000,000 shares of Common Stock to the HealthCor Parties on January 16, 2014; and

WHEREAS,
pursuant to Section 7.9 of the Purchase Agreement and subject to the terms and conditions contained herein, the parties hereto
desire to amend the Purchase Agreement as set forth herein for the purposes of, among other things, providing for an additional
investment in the Company by HealthCor Partners and the New Investors (as defined herein); and

WHEREAS,
the Investors wish to purchase from the Company, and the Company wishes to sell and issue to the Investors, upon the terms
and conditions stated herein and in the Purchase Agreement, (i) additional Notes in the initial aggregate principal amount of
$6,000,000, with a conversion price per share equal to $0.52 (subject to adjustment as described therein) (the “Fifth
Amendment Supplemental Closing Notes”), and (ii) additional Warrants to purchase an aggregate of up to 3,692,308 shares
of the Company’s Common Stock, at an exercise price per share equal to $0.52 (subject to adjustment as described therein)
(the “Fifth Amendment Supplemental Warrants”), in each case on January 12, 2015, or such earlier date as the
Company and the Investors may agree (the “Fifth Amendment Supplemental Closing Date”); and

WHEREAS,
the Company and the Investors are executing and delivering this Amendment in reliance upon the exemption from securities registration
afforded by the provisions of Regulation D, as promulgated by the Commission under the Act.

 

    	

    	 

    

 

NOW,
THEREFORE, in consideration of the mutual promises, representations, warranties and covenants contained herein and in the
Purchase Agreement, which represent integral components of the transactions contemplated hereby and thereby and shall be fully
enforceable by the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which hereby
acknowledged, the Company and the Investors mutually agree as follows:

1.Definitions.
Capitalized terms used in this Amendment but not defined in this Amendment shall have the meanings ascribed to them in the Purchase
Agreement.

2.Amendments
to Purchase Agreement. Section 1.3 of the Purchase Agreement is hereby amended and restated in its entirety to read as follows:

“Sale
of Additional Securities. After the Closing, the Company may sell to the Investors, on the same terms and conditions as those
contained in this Agreement (as amended from time to time), up to $16,000,000 in additional Notes and Warrants to purchase an
additional 7,692,308 shares of Common Stock, and (a) any such additional Notes shall be included within the definition of “Notes”
under this Agreement; (b) any such additional Warrants shall be included within the definition of “Warrants” under
this Agreement; (c) any such additional Notes and additional Warrants shall be included within the definition of “Closing
Securities” under this Agreement; (d) any shares of Common Stock issuable upon conversion of any such additional Notes shall
be included within the definition of “Note Shares” under this Agreement; (e) any shares of Common Stock issuable upon
the exercise of any such additional Warrants shall be included within the definition of “Warrant Shares” under this
Agreement; and (f) any amendment or joinder to this Agreement, the Notes, the Warrants, the Security Agreement, the IP Security
Agreement, the Registration Rights Agreement or any other documents contemplated or necessitated hereby in order to further consummate
the sale of any such additional Notes and/or additional Warrants shall be included within the definition of “Transaction
Documents” under this Agreement. Any such additional Notes shall be substantially in the form of the senior secured convertible
note attached hereto as Exhibit A, with such updates to the “Issuance Date”, “Maturity Date”, “First
Five Year Note Period”, “Conversion Price” and other terms as shall be mutually acceptable to the Company and
the Investors. Any such additional Warrants shall be substantially in the form of common stock warrant attached hereto attached
hereto as Exhibit B, with such updates to the “Expiration Date”, “Warrant Price” and other terms
as shall be mutually acceptable to the Company and the Investors.”

 

    	2

    	 

    

 

3.Joinder
of Additional Investors to Purchase Agreement and Registration Rights Agreement. The Investors other than the HealthCor Parties
(such Investors, the “New Investors”) hereby join in the execution and agree to be bound by, and are hereby
deemed a party to, the Purchase Agreement and the Registration Rights Agreement, as one of the “Investors” under the
Purchase Agreement and one of the “Holders” under the Registration Rights Agreement, in each case for all purposes
thereof. The Company hereby acknowledges and agrees that the New Investors are hereby joining in the execution of and agreeing
to be bound by and will be deemed a party to, the Purchase Agreement and the Registration Rights Agreement, as one of the “Investors”
under the Purchase Agreement and one of the “Holders” under the Registration Rights Agreement for all purposes thereof
and shall be entitled to all of the rights, benefits and terms thereof as an Investor or Holder, as the case may be. By executing
this Amendment, each of the New Investors (severally and not jointly) hereby acknowledges and agrees that it is bound by all terms
and conditions of the Purchase Agreement that apply to an Investor and all of the terms and conditions of the Registration Rights
Agreement that apply to a Holder, and joins in the representations and warranties of the several Investors under Article 3 of
the Purchase Agreement to the extent set forth in Section 7 of this Amendment.

4.No
Further Amendments. Except as amended by this Amendment, the Purchase Agreement shall remain in full force and effect in accordance
with its terms.

5.Issuance
of Fifth Amendment Supplemental Closing Notes and Fifth Amendment Supplemental Warrants. Subject to the terms and conditions
of this Amendment and the Purchase Agreement (including without limitation Section 7.6 of the Purchase Agreement), on the Fifth
Amendment Supplemental Closing Date, each of the Investors listed on Annex I shall severally, and not jointly, purchase
from the Company, and the Company shall sell and issue to each Investor, the Fifth Amendment Supplemental Closing Notes and the
Fifth Amendment Supplemental Warrants in the respective amounts set forth opposite each such Investor’s name on Annex
I in exchange for a cash payment by each such Investor of the amount set forth opposite such Investor’s name on Annex
I (the “Fifth Amendment Supplemental Purchase Price”). The Fifth Amendment Supplemental Closing Notes shall
be substantially in the form attached hereto as Exhibit A-1, and the Fifth Amendment Supplemental Warrants shall be substantially
in the form attached hereto as Exhibit B-1. The closing of the purchase, sale and issuance of the Fifth Amendment Supplemental
Closing Notes and Fifth Amendment Supplemental Warrants (the “Fifth Amendment Supplemental Closing”) shall
take place on the Fifth Amendment Supplemental Closing Date at the offices of Edwards Wildman Palmer LLP, 111 Huntington Avenue,
Boston, Massachusetts 02199, or at such other location as the Company and the Investors shall mutually agree. At the Fifth Amendment
Supplemental Closing, the Company shall have satisfied the closing conditions set forth in subsections (c)-(h), (j), (k) and (l)
of Section 4.1 of the Purchase Agreement as of the Fifth Amendment Supplemental Closing Date (for avoidance of doubt, reading
references to the “Closing Date” in such subsections to refer to the Fifth Amendment Supplemental Closing Date) and
shall deliver to the Investors the Fifth Amendment Supplemental Closing Notes and the Fifth Amendment Supplemental Warrants, each
registered in such name or names as the Investors may designate. Without limiting the foregoing, the Company and the Subsidiaries
of the Company shall each deliver to the Investors at such closing a counterpart to the Amended and Restated Credit Agreement
and the Amended and Restated IP Security Agreement (each as defined below), in each case duly executed by an authorized representative
of the Company or the Subsidiary of the Company, as the case may be. On the Fifth Amendment Supplemental Closing Date, the Investors
shall deliver the Fifth Amendment Supplemental Purchase Price to the Company, payable by wire transfer in same day funds to an
account specified by the Company in writing. The Fifth Amendment Supplemental Closing Notes shall be secured as and to the same
extent as the other Notes issued pursuant to the Purchase Agreement, as described in the Transaction Documents, including, without
limitation, the Security Agreement and IP Security Agreement (each as amended as of the date hereof).

 

    	3

    	 

    

 

6.Bringdown
of Company’s Representations and Warranties. The Company represents and warrants to the Investors that, except as set
forth in a disclosure letter delivered to the Investors as of the Fifth Amendment Supplemental Closing Date, the statements contained
in Article 2 and the first sentence of Section 5.1(k) of the Purchase Agreement are true and correct as of the Fifth
Amendment Supplemental Closing Date as though made as of such date, except to the extent such representations and warranties are
specifically made as of a particular date (in which case such representations and warranties are true and correct as of such other
specified date). For the avoidance of doubt, as a result of the operation of this Section 6 and for purposes hereof, any
representation and warranty made in the Purchase Agreement “as of the Closing Date” shall be deemed to be made as
of the Fifth Amendment Supplemental Closing Date, any reference in a representation and warranty to “the date hereof”
shall be deemed to refer to the date of this Amendment, any retroactive time period set forth in a representation and warranty
shall be deemed to be retroactive from the date of this Amendment for such time period, and any reference to “Closing Securities”
shall be deemed to refer to the Fifth Amendment Supplemental Closing Notes and the Fifth Amendment Supplemental Warrants.

7.Bringdown
of Investors’ Representations and Warranties. Each Investor, severally and not jointly, represents and warrants to the
Company that the statements contained in Article 3 of the Purchase Agreement are true and correct as of the Fifth Amendment
Supplemental Closing Date as though made as of the Fifth Amendment Supplemental Closing Date (for this purpose, reading any reference
to “Closing Securities” in such Article 3 to refer only to the Fifth Amendment Supplemental Closing Notes and
the Fifth Amendment Supplemental Warrants).

8.Form D
and Blue Sky. The Company agrees to file a Form D with respect to the Fifth Amendment Supplemental Closing Notes and
the Fifth Amendment Supplemental Warrants as required under Regulation D and to provide a copy thereof to the Investors promptly
after such filing. The Company shall take such action as is necessary in order to obtain an exemption for or to qualify the Fifth
Amendment Supplemental Closing Notes and the Fifth Amendment Supplemental Warrants for sale to the Investors at the Fifth Amendment
Supplemental Closing pursuant to this Amendment under applicable securities or “Blue Sky” laws of the states of the
United States, and shall provide evidence of any such exemption or qualification so taken to the Investors on or prior to the
Fifth Amendment Supplemental Closing Date promptly upon the request of any Investor.

9.Acknowledgement
and Undertaking by Company. The Company agrees and acknowledges that the transactions described in this Amendment and the
issuance of the Fifth Amendment Supplemental Closing Notes, the Fifth Amendment Supplemental Warrants and shares of Common Stock
upon exercise or conversion of the Fifth Amendment Supplemental Closing Notes and Fifth Amendment Supplemental Warrants are intended
to be exempt from Section 16(b) of the Exchange Act pursuant to one or more rules promulgated thereunder, applicable law and the
Commission’s releases and interpretations, and will, from time to time as and when requested by the Investors, and will
cause its successors and assigns to, execute and deliver or cause to be executed and delivered, to the extent it may lawfully
do so, all such documents and instruments and take, or cause to be taken, to the extent it may lawfully do so, all such further
actions as the Investors may reasonably deem necessary and desirable to facilitate and effect any such exemption.

 

    	4

    	 

    

 

10.Miscellaneous.

a.Ratification
and Confirmation. The Company acknowledges, agrees and confirms that: (x) the Purchase Agreement and each of the other Transaction
Documents, as amended and otherwise modified by the amendments and other modifications specifically provided herein or contemplated
hereby, are and shall continue to be in full force and effect and are hereby in all respects ratified and confirmed; and (y) without
limiting the generality of the foregoing clause (x), (i) all obligations, liabilities and Indebtedness of the Company under the
Transaction Documents, as amended hereby, constitute “Obligations” (as defined in the Security Agreement) secured
by and entitled to the benefits of the security set forth in the Security Agreement and the IP Security Agreement, and the liens
and security interests granted in favor of the Investors under the terms of the Security Agreement and the IP Security Agreement
are and remain perfected, effective, enforceable and valid and such liens and security interests are, in each case, a first priority
lien and security interest (except to the extent otherwise expressly permitted by the Transaction Documents) and such liens and
security interests are hereby in all respects ratified and confirmed, and (ii) the shares of Common Stock issuable upon exercise
or conversion of the 2014 Supplemental Closing Notes and the 2014 Supplemental Warrants shall constitute “Registrable Securities”
under the Registration Rights Agreement. At the Fifth Amendment Supplemental Closing Date, the Company shall deliver to the Investors
an executed copy of the Amended and Restated Pledge and Security Agreement and an executed copy of the Amended and Restated IP
Security Agreement, in the forms set forth as Exhibit C-1 and Exhibit C-2 hereto, respectively, with such alterations
or amendments as the parties thereto may mutually agree (the “Amended and Restated Security Agreement” and
the “Amended and Restated IP Security Agreement”, respectively), in order to reflect the addition of the New
Investors as Securd Parties thereunder and to provide for the appointment of a collateral agent thereunder.

b.Expenses.
The Company will pay and bear full responsibility for the reasonable legal fees and other out-of-pocket costs and expenses of
the Investors attributable to the negotiation and consummation of the transactions contemplated hereby.

c.Further
Assurances. The Company shall duly execute and deliver, or cause to be duly executed and delivered, at its own cost and expense,
such further instruments and documents and to take all such action, in each case as may be necessary or proper in the reasonable
judgment of the Investors to carry out the provisions and purposes of this Amendment.

d.Survival.
The representations, warranties, covenants and agreements made herein shall survive any investigation made by any party hereto,
the execution and delivery of this Amendment and the closing of the transactions contemplated hereby.

 

    	5

    	 

    

 

e.Governing
Law. All questions concerning the construction, interpretation and validity of this Amendment shall be governed by and construed
and enforced in accordance with the domestic laws of the State of Delaware without giving effect to any choice or conflict of
law provision or rule (whether in the State of Delaware or any other jurisdiction) that would cause the application of the laws
of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of the State of Delaware
will control the interpretation and construction of this Amendment, even if under such jurisdiction’s choice of law or conflict
of law analysis, the substantive law of some other jurisdiction would ordinarily or necessarily apply.

f.Construction.
The Company and the Investors acknowledge that the Company and its independent counsel and the Investors and their independent
counsel have jointly reviewed and drafted this document, and agree that any rule of construction and interpretation to the effect
that drafting ambiguities are to be resolved against the drafting party shall not be employed.

g.Counterparts;
Facsimile and Electronic Signatures. This Amendment may be executed in any number of counterparts, and each such counterpart
hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. Counterpart
signatures to this Amendment delivered by facsimile or other electronic transmission shall be acceptable and binding.

h.Headings.
The section and paragraph headings contained in this Amendment are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Amendment.

 

[Signature
Pages Follow]

 

 

    	6

    	 

    

 

IN
WITNESS WHEREOF, each of the undersigned has duly executed this Fifth Amendment to Note and Warrant Purchase Agreement as
of the date first written above.

 

 

	 	COMPANY:
	 	 	 
	 	CareView Communications, Inc., A Nevada corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	 	Name: Steven
G. Johnson
	 	 	Title: President

 

 

	 	INVESTORS:
	 	 	 
	 	HealthCor Partners Fund, L.P.
	 	By: HealthCor Partners Management L.P., as Manager
	 	By: HealthCor Partners Management, G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Jeffrey C. Lightcap
	 	Name: Jeffrey C. Lightcap
	 	Title: Senior Managing Director

 

	 	Address:	HealthCor Partners
	 	 	Carnegie
Hall Towers
	 	 	152
West 57th Street
	 	 	New
York, NY 10019

 

 

	 	HealthCor Hybrid Offshore Master Fund, L.P.
	 	By: HealthCor Hybrid Offshore G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Joseph Healey
	 	Name: Joseph Healey
	 	Title: Co-CEO

 

	 	Address:	HealthCor Partners
	 	 	Carnegie
Hall Towers
	 	 	152
West 57th Street
	 	 	New
York, NY 10019

 

 

[signature
page to Fifth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

 

	 	/s/ Allen Wheeler
	 	Allen Wheeler
	 	 
	 	/s/ Steven Johnson
	 	Steven Johnson
	 	 
	 	/s/ Jason Thompson
	 	Jason Thompson
	 	 
	 	/s/ Sandra McRee
	 	Sandra McRee
	 	 
	 	/s/ Steven B. Epstein
	 	Steven B. Epstein
	 	 
	 	/s/ James R. Higgins
	 	Dr. James R. Higgins
	 	 
	 	/s/ Jeffrey C. Lightcap
	 	Jeffrey C. Lightcap

 

 

[signature
page to Fifth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

ACKNOWLEDGED AND AGREED:

 

	CareView Communications, Inc., A Texas corporation	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	Steven G. Johnson	 
	Title: 	President	 
	 	 	 
	CareView Operations, LLC	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	Steven G. Johnson	 
	Title: 	President	 

  

 

[signature
page to Fifth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

Annex
I

 

Investors

 

	Investor	Fifth
    Amendment Supplemental Closing Notes	Fifth
    Amendment Supplemental Warrants	Fifth
    Amendment Supplemental Purchase Price
	HealthCor
    Partners Fund, L.P.	$1,000,000	615,385	$1,000,000
	HealthCor
    Hybrid Offshore Master Fund, L.P.	N/A	N/A	N/A
	Allen
    Wheeler	$500,000	307,692	$500,000
	Steven
    Johnson	$750,000	461,539	$750,000
	Jason
    Thompson	$200,000	123,077	$200,000
	Sandra
    McRee	$100,000	61,538	$100,000
	Steven
    Epstein	$450,000	276,923	$450,000
	Dr.
    James Higgins	$500,000	307,692	$500,000
	Jeffrey
    C. Lightcap	$2,500,000	1,538,462	$2,500,000
	TOTAL	$6,000,000	3,692,308	$6,000,000

 

 

    	 

    	 

    

 

Exhibit
A-1

 

Form
of Fifth Amendment Supplemental Closing Notes

 

See attached.

 

 

 

 

    	 

    	 

    

 

Exhibit
B-1

 

Form
of Fifth Amendment Supplemental Warrants

 

See attached.

 

    	 

    	 

    

 

Exhibit
C-1

 

Form
of Amended and Restated Pledge and Security Agreement

 

See attached.

 

    	 

    	 

    

 

 

Exhibit
D-1

 

Form
of Amended and Restated IP Security Agreement

 

See attached.Careview Communications, Inc. 

EXHIBIT
10.23 

 

Exhibit
A-1

SENIOR
SECURED CONVERTIBLE NOTE

NEITHER
THE ISSUANCE AND SALE OF THIS NOTE NOR ANY SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND
THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I)
IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION
OF THIS NOTE UNDER THE SECURITIES ACT, AS APPLICABLE, OR (B) AN OPINION OF COUNSEL (SELECTED BY THE HOLDER AND REASONABLY ACCEPTABLE
TO THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT THIS NOTE AND THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION
OF THIS NOTE MAY BE OFFERED FOR SALE, SOLD, ASSIGNED OR TRANSFERRED PURSUANT TO AN EXEMPTION FROM REGISTRATION; PROVIDED THAT
SUCH OPINION OF COUNSEL SHALL NOT BE REQUIRED IN CONNECTION WITH ANY SUCH SALE, ASSIGNMENT OR TRANSFER TO AN INSTITUTIONAL ACCREDITED
INVESTOR THAT IS, PRIOR TO SUCH SALE, ASSIGNMENT OR TRANSFER, AN AFFILIATE OF THE HOLDER OF THIS NOTE, OR (II) UNLESS THE HOLDER
PROVIDES THE COMPANY WITH ASSURANCE (REASONABLY SATISFACTORY TO THE COMPANY) THAT SUCH NOTE OR THE SHARES OF COMMON STOCK ISSUABLE
UPON THE CONVERSION OF THE NOTE CAN BE SOLD, ASSIGNED OR TRANSFERRED PURSUANT TO RULE 144.

ANY
TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE, INCLUDING, WITHOUT LIMITATION, SECTIONS 3(c)(iii) AND
13(a) HEREOF. THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY
BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION 3(c)(iii) OF THIS NOTE.

 

 

 

 

    	 

    	 

    

 

CAREVIEW
COMMUNICATIONS, INC.

SENIOR
SECURED CONVERTIBLE NOTE

	Issuance
    Date:  [_________], 2015	Principal
    Amount:  U.S. $[__________]
	 	(subject
    to Section 3(c)(iii) hereof)

 

 

FOR
VALUE RECEIVED, CareView Communications, Inc., a Nevada corporation (the “Company”), hereby promises
to pay to [______________] or the registered assign(s) thereof (“Holder”) the principal amount set forth
above (as increased and/or decreased pursuant to the terms hereof by reason of the accrual of Interest, partial conversion or
otherwise, and together with the principal amount of any additional convertible debt instruments issued by the Company to the
Holder in accordance herewith, the “Principal”) when due, whether upon the Maturity Date, acceleration or
otherwise (in each case in accordance with the terms hereof), together with accrued interest (“Interest”)
on any outstanding Principal at the First Five Year Interest Rate or the Second Five Year Interest Rate, as applicable, from
the date hereof (the “Issuance Date”) until the same becomes due and payable, whether upon the Maturity
Date, acceleration, conversion or otherwise (in each case, in accordance with the terms hereof). This Senior Secured
Convertible Note (this “Note”) is being issued pursuant to that certain Note and Warrant Purchase
Agreement, dated as of April 21, 2011, as amended by a Note and Warrant Amendment Agreement entered into as of December 20,
2011, a Second Amendment to Note and Warrant Purchase Agreement dated as of January 31, 2012, a Third Amendment to Note and
Warrant Purchase Agreement dated as of August 20, 2013, a Fourth Amendment to Note and Warrant Purchase Agreement dated as of
January 16, 2014 and a Fifth Amendment to Note and Warrant Purchase Agreement dated as of December 15, 2014, by and among the
Company, the Holder and the other Investors named therein (the “Purchase Agreement”), and is entitled to
the benefits of, and evidences obligations incurred under, the Purchase Agreement and the other Transaction Documents (as
defined in the Purchase Agreement), to which reference is made for a description of the security for this Note and for a
statement of the terms and conditions on which the Company is permitted and required to make prepayments and repayments of
principal of the obligations evidenced hereby and on which such obligations may be declared to be immediately due and
payable. This Note represents a full recourse obligation of the Company.

Certain
capitalized terms used herein are defined in Section 23.

(1)MATURITY.
On the Maturity Date, the Holder shall surrender this Note to the Company and the Company shall pay to the Holder an amount in
cash representing all outstanding Principal, accrued and unpaid Interest and accrued and unpaid Late Charges (as defined in Section
19(b)), if any. The “Maturity Date” shall be [___________], 2025.

 

    	 

    	 

    

 

 

(2)INTEREST;
INTEREST RATE.

(a)So
long as no Event of Default has occurred and is continuing, the outstanding Principal balance of this Note shall accrue Interest
from the Issuance Date through [___________], 2020 (the “First Five Year Note Period”), at the rate of twelve
and one-half percent (12.5%) per annum (based on a 360-day year and the actual number of days elapsed in any partial year)
(the “First Five Year Interest Rate”), compounding quarterly, which accrued Interest shall be added to the
outstanding Principal balance of this Note on the last day of each calendar quarter and shall thereafter itself, as part of such
Principal balance, accrue Interest at the First Five Year Interest Rate (and, during the Second Five Year Note Period (as defined
below), at the Second Five Year Interest Rate (as defined below)), compounding quarterly. All such accrued Interest added to the
outstanding Principal balance pursuant to the immediately preceding sentence shall be payable on the same terms and subject to
the same conditions set forth herein. Upon the occurrence of an Event of Default, Interest shall be calculated at the Default
Rate as set forth in Section 2(c) below.

(b)So
long as no Event of Default has occurred and is continuing, the outstanding Principal balance of this Note shall accrue Interest
from and after the end of the First Five Year Note Period through the Maturity Date (the “Second Five Year Note Period”),
at the rate of ten percent (10%) per annum (based on a 360-day year and the actual number of days elapsed in any partial year)
(the “Second Five Year Interest Rate”). The Interest accruing during the Second Five Year Note Period may be
paid quarterly in arrears in cash or, at the Company’s option, such Interest may be added to the outstanding Principal balance
of the Note on the last day of each calendar quarter and shall thereafter itself, as part of such Principal balance, accrue Interest
at the Second Five Year Interest Rate, compounding quarterly. All such accrued Interest added to the outstanding Principal balance
pursuant to the immediately preceding sentence shall be payable on the same terms and subject to the same conditions set forth
herein. Upon the occurrence of an Event of Default, Interest shall be calculated at the Default Rate as set forth in Section 2(c)
below.

(c)From
and after the date such Event of Default occurred, the First Five Year Interest Rate or the Second Five Year Interest Rate, whichever
is then applicable, shall be increased by five percent (5%) and otherwise applied consistently with the provisions of Sections
2(a) and 2(b) (the “Default Rate”).

 

    	 

    	 

    

 

 

(d)

(i)In
addition to the foregoing, if any Major Event occurs at any time during the First Five Year Note Period, then all amounts of Interest
that are then scheduled to be paid or accrued pursuant to Section 2(a) through and including the last day of the First Five Year
Note Period, but that have not yet been paid pursuant to Section 2(a) (such amount, the “First Five Year Major Event
Interest Amount”), will accelerate and become immediately due and payable by the Company by the issuance to the Holder
of an additional convertible debt instrument with the same terms as this Note, in a principal amount equal to the First Five Year
Major Event Interest Amount, and, at any time from and after the occurrence of the Major Event, the Holder may, at its option,
elect to (A) convert this Note and such convertible debt instrument at the then effective Conversion Rate or (B) redeem all or
any portion of the outstanding Principal balance of this Note and such convertible debt instrument, provided that for so long
as this Note or such convertible debt instrument remain outstanding, subject to Section 2(d)(ii) below, no additional Interest
shall accrue on this Note or such additional convertible debt instrument until the commencement of the Second Five Year Note Period.
If any Major Event occurs at any time during the Second Five Year Note Period, then all amounts of Interest that are then scheduled
to be paid or accrued pursuant to Section 2(b) through and including the last day of the Second Five Year Note Period (assuming
for this purpose that the Company would elect to pay all such Interest in cash), but that have not yet been paid pursuant to Section
2(b) (such amount, the “Second Five Year Major Event Interest Amount”), will accelerate and become immediately
due and payable by the Company by the issuance to the Holder of an additional convertible debt instrument with the same terms
as this Note and in a principal amount equal to the Second Five Year Major Event Interest Amount or, at the Company’s option,
by cash payment in immediately available funds of an amount equal to the Second Five Year Major Event Interest Amount paid within
five (5) Business Days of the occurrence of the Major Event. At any time following the occurrence of the Major Event, the Holder
may, at its option, elect to (X) convert this Note and such convertible debt instrument (if any) at the then effective Conversion
Rate or (Y) redeem all or any portion of the outstanding Principal balance of this Note and such convertible debt instrument (if
any), provided that, for so long as this Note or any such convertible debt instrument remain outstanding, subject to Section 2(d)(ii)
below, no additional Interest shall accrue on this Note or such additional convertible debt instrument for the duration of the
Second Five Year Note Period. For purposes of this Note, the term “Major Event” shall mean the occurrence of
(i) the signing of a definitive agreement or a series of agreements for the transfer, sale, lease or license of all or substantially
all of the Company’s assets or capital securities; (ii) the signing of a definitive agreement to consolidate or merge with
or into another Person (whether or not the Company is the Successor Entity) that results or would result, after giving effect
to the consummation of the transactions contemplated by such agreement, in such other Person (or the holders of such other Person’s
capital stock immediately prior to the transaction) (other than the Holder or its Affiliates) being or becoming the beneficial
owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of thirty-five percent (35%) or more of any class
of the Company’s or the Successor Entity’s outstanding capital securities; (iii) the signing of a definitive agreement
or a series of agreements to consummate a stock acquisition or sale or other business combination (including, without limitation,
a reorganization, recapitalization, or spin-off), or series thereof, with any other Person or Persons (other than the Holder or
its Affiliates) that results or would result, after giving effect to the consummation of the transactions contemplated by such
agreement or agreements, in such other Person or Persons being or becoming the beneficial owner (within the meaning of Rule 13d-3
promulgated under the Exchange Act) of thirty-five percent (35%) or more of any class of the Company’s outstanding capital
securities; (iv) the commencement or other public announcement by any Person (other than the Company, the Holder or the Holder’s
Affiliates) of a purchase, tender or exchange offer for 35% or more of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or
party to, such purchase, tender or exchange offer), (v) any “person” or “group” (as these terms are used
for purposes of Sections 13(d) and 14(d) of the Exchange Act) (other than the Holder or its Affiliates) is or shall
become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of either
(x) 35% or more of the aggregate ordinary voting power represented by issued and outstanding Common Stock or (y) 35%
or more of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by such Person or Persons
as of the date hereof or (vi) the public announcement by any Person, Persons or group (other than the Company, the Holder or the
Holder’s Affiliates) of a bona fide intention to enter into any of the agreements or to engage in or commence any
of the actions described in clauses (i) through (v) above, or otherwise reflecting an intent to acquire the Company or all or
substantially all of its assets or capital securities, or the public announcement by the Company of its receipt of a communication
from such a Person, Persons or group evidencing the same.

(ii)Notwithstanding
the foregoing, in the event that, following a Major Event, an Event of Default occurs during the First Five Year Note Period while
any portion of this Note and/or any convertible debt instrument issued pursuant to Section 2(d)(i) remains outstanding (such outstanding
portion, the “Post EOD Principal”), the Company shall issue to the Holder an additional convertible debt instrument
with the same terms as this Note and with a face principal amount equal to the difference (to the extent such difference is positive)
between (A) the applicable EOD Accelerated Interest (as defined in Section 4(b)) on such Post EOD Principal, and (B) the First
Five Year Major Event Interest Amount attributable to the Post EOD Principal and paid under Section 2(d)(i), and at any time following
the occurrence of the Event of Default, the Holder may, at its option, elect to convert such additional convertible debt instrument
at the then effective Conversion Rate or redeem all or any portion of the outstanding Principal balance of such convertible debt
instrument. In the event that, following a Major Event, an Event of Default occurs during the Second Five Year Note Period while
any Post EOD Principal remains outstanding, the Company shall issue to the Holder an additional convertible debt instrument with
the same terms as this Note and with a face principal amount equal to the difference (to the extent such difference is positive)
between (X) the applicable EOD Accelerated Interest attributable to such Post EOD Principal and (Y) the Second Five Year Major
Event Interest Amount attributable to the Post EOD Principal and paid under Section 2(d)(i), and at any time following the occurrence
of the Event of Default, the Holder may, at its option, elect to convert such additional convertible debt instrument at the then
effective Conversion Rate or redeem all or any portion of the outstanding Principal balance of such convertible debt instrument,
provided, however, that the Company shall also have the option of paying the foregoing amount in cash upon the occurrence of such
Event of Default during the Second Five Year Note Period.

    	 

    	 

    

(e)Notwithstanding
any other provision of this Note, the aggregate annual interest rate payable with respect to this Note (including all charges
and fees deemed to be interest pursuant to applicable law) shall not exceed the maximum annual rate permitted by applicable law.
In the event the aggregate annual interest rate payable with respect to this Note (including all charges and fees deemed to be
interest under applicable laws) exceeds the maximum legal rate, the Company shall only pay Interest to the Holder at the maximum
permitted rate and the Company shall continue to make such Interest payments at the maximum permitted rate until all amounts,
fees and obligations required to be paid hereunder have been paid in full.

 

(f)This
Note is one of a series of notes issued by the Company pursuant to the Purchase Agreement. Such Notes are referred to herein as
the “Notes,” and the holders thereof (including the Holder) are referred to herein as the “Investors.”
The right of an Investor to receive payments of Principal and Interest under this Note shall be pari passu with the rights
of the other Investors to receive payments of Principal and Interest under their respective Notes, and the Company covenants
that any payments made by it with respect to the Notes shall be made pro rata among the Investors determined based
on the ratio of the outstanding balance of Principal and Interest under each Note divided by the aggregate outstanding balance
of Principal and Interest under all Notes.  By the Holder’s acceptance of this Note, the Holder agrees to the foregoing
sentence.

 

    	 

    	 

    

 

(3)CONVERSION
OF NOTE. This Note shall be convertible into shares of Common Stock, on the terms and conditions set forth in this Section
3.

(a)Conversion
Right. At any time or times on or after the Issuance Date, the Holder shall be entitled to convert any portion of the outstanding
and unpaid Conversion Amount (as defined below) into fully paid and nonassessable shares of Common Stock in accordance with Section
3(c), at the Conversion Rate (as defined below). The Company shall not issue any fraction of a share of Common Stock upon any
conversion. If any conversion would result in the issuance of a fraction of a share of Common Stock, the Company shall round such
fraction of a share of Common Stock to the nearest whole share but shall have no obligation to pay the Holder for any fraction
of a share of Common Stock forfeited as a result of such rounding. The Company shall pay any and all stock transfer, stamp, documentary
and similar taxes (excluding any taxes on the income or gain of the Holder) that may be payable with respect to the issuance and
delivery of shares of Common Stock to the Holder upon conversion of any Conversion Amount. To the extent permitted by law, the Company
and the Holder acknowledge and agree that any conversion of all or any portion of the Conversion Amount into
shares of Common Stock pursuant to the terms of this Section 3(a) will not be treated as a taxable transaction
and the Company and the Holder agree to report any such conversion in a manner consistent with the foregoing treatment.

(b)Conversion
Rate. The number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant to Section 3(a) (the
“Conversion Rate”) shall be determined by dividing (x) such Conversion Amount by (y) the Conversion Price.

(i)“Conversion
Amount” means the sum of (A) the portion of the Principal to be converted with respect to which this determination is
being made, (B) accrued and unpaid Interest with respect to such Principal and (C) accrued and unpaid Late Charges with respect
to such Principal and Interest.

(ii)“Conversion
Price” means $0.52, subject to adjustment as provided herein (including, without limitation, adjustment pursuant to
Section 6).

 

    	 

    	 

    

(c)Mechanics
of Conversion.

(i)Optional
Conversion. To convert any Conversion Amount into shares of Common Stock on any date (a “Conversion Date”),
the Holder shall (A) transmit by facsimile (or otherwise deliver), for receipt on or prior to 4:00 p.m., Dallas, TX time, on such
date, a copy of an executed notice of conversion in the form attached hereto as Exhibit I (the “Conversion Notice”)
to the Company and (B) if required by Section 3(c)(iii), cause this Note to be delivered to the Company as soon as practicable
on or following such date. On or before 4:00 p.m., Dallas, TX time, on the first (1st) Business Day following the date
of receipt of a Conversion Notice, the Company shall transmit by facsimile a confirmation of receipt of such Conversion Notice
to the Holder (at the facsimile number provided in the Conversion Notice) and the Company’s transfer agent, if any (the
“Transfer Agent”). On or before 4:00 p.m., Dallas, TX time, on the third (3rd) Business Day following
the date of receipt of a Conversion Notice (the “Share Delivery Date”), the Company shall (X) provided
the Transfer Agent is participating in the DTC Fast Automated Securities Transfer Program, cause the Transfer Agent to credit
such aggregate number of shares of Common Stock to which the Holder shall be entitled to the Holder’s or its designee’s
balance account with DTC through its Deposit/Withdrawal At Custodian (“DWAC”) system, or (Y) if the Transfer
Agent is not participating in the DTC Fast Automated Securities Transfer Program, or if the Holder otherwise requests, issue and
deliver to the address as specified in the Conversion Notice, a certificate, registered in the name of the Holder or its designee,
for the number of shares of Common Stock to which the Holder shall be entitled. If this Note is physically surrendered for conversion
as required by Section 3(c)(iii) and the outstanding Principal of this Note is greater than the Principal portion of the Conversion
Amount being converted, then the Company shall as soon as practicable and in no event later than three (3) Business Days after
receipt of this Note and at its own expense, issue and deliver to the Holder a new Note (in accordance with Section 13(d)), representing
the outstanding Principal not converted. The Person or Persons entitled to receive the shares of Common Stock issuable upon a
conversion of this Note shall be treated for all purposes as the record holder or holders of such shares of Common Stock on the
Conversion Date.

(ii)Company’s
Failure to Timely Convert. If, at any time, the Company shall fail to credit the Holder’s balance account with DTC or
issue a certificate to the Holder, as the case may be, upon conversion of any Conversion Amount on or prior to the date which
is seven (7) Business Days after the Conversion Date (a “Conversion Failure”), then (A) the Company shall pay
damages to the Holder for each day of such Conversion Failure in an amount equal to 1.5% of the product of (I) the sum of the
number of shares of Common Stock not issued to the Holder on or prior to the Share Delivery Date and to which the Holder is entitled,
and (II) the Closing Sale Price of the Common Stock on the Share Delivery Date and (B) the Holder, upon written notice to the
Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, any portion of this
Note that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice shall
not affect the Company’s obligations to make any payments which have accrued prior to the date of such notice pursuant to
this Section 3(c)(ii) or otherwise.

(iii)Book-Entry.
Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note in accordance with the
terms hereof, the Holder shall not be required to physically surrender this Note to the Company unless (A) the full Conversion
Amount represented by this Note is being converted or (B) the Holder has provided the Company with prior written notice (which
notice may be included in a Conversion Notice) requesting physical surrender and reissue of this Note. The Holder and the Company
shall maintain records showing the Principal, Interest and Late Charges converted and the dates of such conversions or shall use
such other method, reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Note
upon conversion.

(iv)Disputes.
In the event of a dispute between the Company and the Holder of this Note as to the number of shares of Common Stock issuable
to the Holder in connection with a conversion of this Note, the Company shall issue to the Holder the number of shares of Common
Stock not in dispute and resolve such dispute in accordance with Section 18.

 

    	 

    	 

    

 

(4)RIGHTS
UPON EVENT OF DEFAULT.

(a)Event
of Default. Each of the following events shall constitute an “Event of Default”:

(i)the
Company’s failure to pay to the Investors any amount of Principal when and as due under the Notes (including, without limitation,
upon a redemption request pursuant to Section 2(d));

(ii)the
Company’s failure to pay to the Investors any amount of Interest, Late Charges or other amounts (other than the amounts
specified in clause (i)) when and as due under the Notes if such failure continues for a period of at least three (3) Business
Days;

(iii)any
acceleration prior to maturity of any Indebtedness referred to in clause (a) or (b) of the definition thereof of the Company or
any of its Subsidiaries consisting of principal individually or in the aggregate equal to or greater than $250,000;

(iv)the
Company or any of its Subsidiaries, pursuant to or within the meaning of Title 11, U.S. Code, or any similar Federal, foreign
or state law for the relief of debtors (collectively, “Bankruptcy Law”), (A) commences a voluntary case, (B)
consents to the entry of an order for relief against it in an involuntary case, (C) consents to the appointment of a receiver,
trustee, assignee, liquidator or similar official (a “Custodian”), (D) makes a general assignment for the benefit
of its creditors or (E) admits in writing that it is generally unable to pay its debts as they become due;

(v)a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that is not vacated, set aside or reversed
within sixty (60) days that (A) is for relief against the Company or any of its Subsidiaries in an involuntary case, (B) appoints
a Custodian of the Company or any of its Subsidiaries or (C) orders the liquidation of the Company or any of its Subsidiaries;

(vi)a
final judgment or judgments for the payment of money aggregating in excess of $2,000,000 are rendered against the Company or any
of its Subsidiaries and which judgments are not, within sixty (60) days after the entry thereof, bonded, discharged or stayed
pending appeal, or are not discharged within sixty (60) days after the expiration of such stay; provided, however, that any judgment
which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $2,000,000 amount
set forth above so long as the Company provides the Holder a written statement from such insurer or indemnity provider (which
written statement shall be reasonably satisfactory to the Holder) to the effect that such judgment is covered by insurance or
an indemnity and the Company will receive the proceeds of such insurance or indemnity within sixty (60) days of the issuance of
such judgment;

(vii)the
Company or any Subsidiary breaches any negative covenant in any Transaction Document;

 

    	 

    	 

    

 

(viii)the
Company breaches any affirmative covenant or agreement or materially breaches any representation or warranty in any Transaction
Document, and such breach continues for a period of at least thirty (30) days;

(ix)if
at any time while any portion of the Notes remain outstanding (x) the Board of Directors fails to include one (1) Director designated
by the Holder(s) of at least a majority of the Principal amount of the Notes outstanding, voting as a separate class (the “Noteholder
Director”), provided that the Company shall have thirty (30) Business Days following the resignation, removal or death
or disability of the Noteholder Director to appoint a successor Noteholder Director designated by the Holder(s) of at least a
majority of the Principal amount of the Notes outstanding, voting as a separate class, unless such failure is the result of the
failure by such Holders to notify the Company of the name of the replacement Noteholder Director, in which event the thirty (30)
Business Day period shall be extended until a date which is ten (10) Business Days after notice of the name and background of
the replacement Noteholder Director is given to the Company, or (y) without the consent of the Noteholder Director (or, in the
absence of a Noteholder Director, the Holder(s) of at least a majority of the Principal amount of the Notes outstanding), the
Board of Directors exceeds seven (7) directors, or the Compensation Committee or Nominating Committee (or other committees serving
similar functions) of the Board of Directors exceeds three (3) members, or (z) the Noteholder Director is not afforded the right
to serve as a member of each of the Compensation Committee and Nominating Committee (or committees serving similar functions);

(x)the
failure of the Company for a period of ninety (90) days following the resignation and/or departure of Steven Johnson to engage
a replacement therefor that is reasonably acceptable to the Investors holding a majority in principal amount of the Notes issued
as of the date hereof (the “Majority November 2014 Investors”);

(xi)[Intentionally
omitted];

(xii)the
Company or any Subsidiary shall fail to make any payment (whether of principal, interest or otherwise and regardless of amount)
in respect of any Indebtedness in excess of $250,000 (“Material Indebtedness”), when and as the same shall
become due and payable, after giving effect to any grace period with respect thereto;

(xiii)any
event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables
or permits (with or without the giving of notice, the lapse of time or both) the holder or holders of any Material Indebtedness
or any trustee or agent on its or their behalf to cause such Material Indebtedness to become due, or to require the prepayment,
repurchase, redemption or defeasance thereof, prior to its scheduled maturity;

(xiv)there
shall occur any material loss theft, damage or destruction of any Collateral (as defined in the Security Agreement) not fully
covered (subject to such reasonable deductibles as the Holder shall have approved) by insurance; or

 

    	 

    	 

    

 

(xv)either
(a) the Company’s Board of Directors, a committee of the Board of Directors or the officer or officers of the Company authorized
to take such action if board action is not required, concludes that any previously issued financial statements, including interim
periods, should no longer be relied upon because of an error in such financial statements as addressed in FASB Accounting Standards
Codification Topic 250, as may be modified, supplemented or succeeded, or (b) the Company is advised by, or receives notice from,
its independent accountant that disclosure should be made or action should be taken to prevent future reliance on a previously
issued audit report or completed interim review related to previously issued financial statements, and in either case the amended
financial statements required in order to permit reliance on such financial statements for the affected periods have not been
filed with the SEC within ninety (90) days of the earliest such event; provided, however that
if the facts and/or circumstances underlying the Event of Default described in this Section 4(a)(xv) would also create or
constitute a separate Event of Default under this Note, the cure period set forth in this Section 4(a)(xv) shall not
supersede or prevent the application of any shorter cure period associated with such other applicable Event of Default, which
may be enforced separately and independently.

(b)Rights
Upon Event of Default. Promptly after the occurrence of an Event of Default, the Company shall deliver written notice thereof
(an “Event of Default Notice”) to the Holder, and the Majority November 2014 Investors may, at their option,
by notice to the Company (an “Event of Default Acceleration Notice”), declare the Default Amount to be due
and payable upon demand (an “Acceleration”), provided that upon the occurrence of an Event of Default
described in Sections 4(a)(iv) and 4(a)(v) above, such Acceleration shall occur automatically without requiring the delivery of
an Event of Default Acceleration Notice, such that the Default Amount shall automatically become immediately due and payable without
any further notice, demand or other action. For purposes hereof, the “Default Amount” shall equal the entire
unpaid Principal balance under this Note, plus all previously accrued and unpaid Interest and Late Charges, together with all
future Interest (calculated at the Default Rate pursuant to Section 2(c)) scheduled to accrue during the First Five Year Note
Period (if such Acceleration occurred during the First Five Year Note Period) or the Second Five Year Note Period (if such Acceleration
occurred during the Second Five Year Note Period) (such future Interest amount the “EOD Accelerated Interest”),
in each case without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Company.
Following an Acceleration (other than an Acceleration based on an Event of Default described in Sections 4(a)(iv) and 4(a)(v)
above), the Holder shall have the right, but not the obligation, to demand payment in full of the Default Amount at any time prior
to the original Maturity Date of this Note upon written notice to the Company (a “Demand Notice”). In the event
a Demand Notice is not immediately given upon the occurrence of an Event of Default, or the Company otherwise does not immediately
pay the Default Amount when due, interest shall continue to accrue on the Note as provided herein, provided that (i) upon an Acceleration
that occurs during the First Five Year Note Period, such Default Amount shall not accrue additional Interest until the commencement
of the Second Five Year Note Period, and (ii) upon an Acceleration that occurs during the Second Five Year Note Period, such Default
Amount shall not accrue any additional Interest for the duration of the Second Five Year Note Period. The Company shall deliver
the applicable Default Amount to the Holder (x) in the case of an Event of Default under Section 4(a)(iv) or 4(a)(v), immediately,
and (y) in the case of any other Event of Default, within five (5) Business Days after the Company’s receipt of the Demand
Notice. In the event the Company fails to deliver the Default Amount as described above, the Holder shall be permitted to exercise
such rights as a secured party or otherwise hereunder or under the other Transaction Documents to the extent permitted by applicable
law.

 

    	 

    	 

    

 

(5)RIGHTS
UPON A CHANGE OF CONTROL.

(a)Assumption.
The Company shall not enter into or be party to a transaction resulting in a Change of Control unless the Successor Entity assumes
in writing all of the obligations of the Company under this Note and the other Transaction Documents in accordance with the provisions
of this Section 5(a) pursuant to written agreements on or prior to the consummation of such Change of Control, including the agreement
to deliver to the Holder of this Note in exchange for this Note a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Note, including, without limitation, having a principal amount and interest
rate equal to the principal amounts and the interest rates of this Note (the “Successor Note”). Upon the occurrence
of any Change of Control, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Change of Control, the provisions of this Note referring to the “Company” shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Note with
the same effect as if such Successor Entity had been named as the Company herein, until such time as the Successor Note is delivered.
Upon consummation of a Reclassification or Change of Control as a result of which holders of Common Stock shall be entitled to
receive stock, securities, cash, assets or any other property with respect to or in exchange for such Common Stock, the Company
or Successor Entity, as the case may be, shall deliver to the Holder confirmation that there shall be issued upon conversion of
this Note at any time after the consummation of such Reclassification or Change of Control, in lieu of the shares of Common Stock
(or other securities, cash, assets or other property) issuable upon the conversion of this Note prior to such Reclassification
or Change of Control, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other
purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of such Reclassification
or Change of Control had this Note been converted immediately prior to such Reclassification or Change of Control, as adjusted
in accordance with the provisions of this Note. The provisions of this Section 5(a) shall apply similarly and equally to successive
Change of Control transactions and shall be applied without regard to any limitations on the conversion of this Note.

(6)RIGHTS
UPON ISSUANCE OF OTHER SECURITIES.

(a)Record
Date. If the Company takes a record of the holders of Common Stock for the purpose of entitling them to receive a dividend
or other distribution payable in Common Stock, Options or in Convertible Securities, then such record date will be deemed to be
the date of the issue or sale of the Common Stock deemed to have been issued or sold upon the declaration of such dividend or
the making of such other distribution, as the case may be.

 

    	 

    	 

    

 

(b)Adjustment
of Conversion Rate upon Subdivision or Combination of Common Stock; Stock Dividends. If the Company at any time, or from time
to time, subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding
shares of Common Stock into a greater number of shares, the Conversion Price in effect immediately prior to such subdivision will
be proportionately reduced. If the Company at any time, or from time to time, combines (by combination, reverse stock split or
otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion Price
in effect immediately prior to such combination will be proportionately increased. Any adjustment under this Section 6(b) shall
become effective at the close of business on the date the subdivision or combination becomes effective or, in the case of a stock
dividend, the date of such event.

(c)(i)Adjustment
of Conversion Rate upon Cash Dividends and Distributions. If the Company at any time, or from time to time, pays a dividend
or makes a distribution in cash to the record holders of any class of Common Stock, then immediately after the close of business
on the day that the Common Stock trades ex-distribution, the Conversion Price then in effect shall be reduced to an amount equal
to the product of (i) the Conversion Price in effect immediately prior to such dividend or distribution and (ii) the quotient
determined by dividing (A) the Closing Sale Price of the Common Stock on the day that the Common Stock trades ex-distribution
by (B) the sum of (1) the Closing Sale Price of the Common Stock on the day that the Common Stock trades ex-distribution plus
(2) the amount per share of such dividend or distribution. The Company shall not be required to give effect to any adjustment
in the Conversion Price pursuant to this Section 6(c) unless and until the net effect of one or more adjustments (each of which
shall be carried forward until counted toward an adjustment), determined in accordance with this Section 6(c), shall have resulted
in a change of the Conversion Price by at least 1%, and when the cumulative net effect of more than one adjustment so determined
shall be to change the Conversion Price by at least 1%, such change in the Conversion Price shall then be given effect.

(ii)Adjustment
of Conversion Rate upon Distributions of Capital Stock, Indebtedness or Other Non-Cash Assets. If the Company at any time,
or from time to time, distributes any shares of capital stock of the Company (other than Common Stock), evidences of indebtedness
or other non-cash assets (including securities of any person other than the Company but excluding (1) dividends or distributions
paid exclusively in cash or (2) dividends or distributions referred to in Section 6(b)) to the record holders of any class of
Common Stock, then the Conversion Price then in effect shall be reduced to an amount equal to the product of (A) the Conversion
Price then in effect and (B) a fraction of which the numerator shall be the Closing Sale Price per share of the Common Stock on
the record date fixed for determination of stockholders entitled to receive such distribution less the fair market value on such
record date (as determined by the Board of Directors) of the portion of the capital stock, evidences of indebtedness or other
non-cash assets so distributed applicable to one share of Common Stock (determined on the basis of the number of shares of Common
Stock outstanding on the record date) and of which the denominator shall be the Closing Sale Price per share of the Common Stock
on such record date.

(d)[Intentionally
omitted.]

 

    	 

    	 

    

 

(e)Other
Events; Other Dividends and Distributions. If any event occurs of the type contemplated by the provisions of this Section
6 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights,
phantom stock rights or other rights with equity features), then the Company’s Board of Directors shall, in good faith,
make an adjustment in the Conversion Price so as to protect the rights of the Holder under this Note; provided that no such adjustment
will increase the Conversion Price as otherwise determined pursuant to this Section 6.

(f)Notice
of Adjustment. Whenever the Conversion Price is adjusted pursuant to this Section 6, the Company shall promptly mail notice
of such adjustment to the Holder, which notice shall set forth the Conversion Price after adjustment, the date on which such adjustment
became effective and a brief statement of the facts resulting in such adjustment.

(7)NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Note, and will
at all times in good faith carry out all of the provisions of this Note and take all action as may be required to protect the
rights of the Holder of this Note.

(8)RESERVATION
OF AUTHORIZED SHARES.

(a)Reservation.
The Company shall at all times reserve out of its authorized and unissued shares of Common Stock a number of shares of Common
Stock equal to 120% of the Conversion Rate with respect to the full Conversion Amount of this Note, solely for the purpose of
effecting the conversion of this Note (the “Required Reserve Amount”).

(b)Insufficient
Authorized Shares. If at any time while this Note remains outstanding the Company does not have a sufficient number of authorized
and unreserved shares of Common Stock to satisfy its obligation to reserve the Required Reserve Amount (an “Authorized
Share Failure”), then the Company shall take all action necessary to increase the Company’s authorized shares
of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount. Without limiting the generality
of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event
later than seventy-five (75) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its
stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting,
the Company shall provide each stockholder with a proxy statement and shall use its commercially reasonable efforts to solicit
its stockholders’ approval of such increase in authorized shares of Common Stock and to cause its board of directors to
recommend to the stockholders that they approve such proposal.

(9)VOTING
RIGHTS. The Holder shall have no voting rights as the Holder of this Note, except as required by law, including, but not limited
to, the General Corporation Law of the State of Nevada, and as expressly provided in this Note, the Company’s Charter or
any of the other Transaction Documents.

(10)OTHER
COVENANTS.

 

    	 

    	 

    

 

(a)Listing.
The Company shall promptly secure the listing of all of the Registrable Securities (as defined in the Registration Rights Agreement)
upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed (subject
to official notice of issuance) and shall maintain such listing of all Registrable Securities from time to time issuable under
the terms of the Transaction Documents. The Company shall maintain the Common Stock’s authorization for quotation on the
principal exchange or market in which it is listed. Neither the Company nor any of its Subsidiaries shall take any action which
would be reasonably expected to result in the delisting or suspension of the Common Stock on the principal market in which it
is listed, other than in connection with a transfer of listing to an Eligible Market. The Company shall pay all fees and expenses
in connection with satisfying its obligations under this Section 10(a).

(b)Quarterly
Report of Outstanding Principal and Interest. The Company covenants to deliver to the Holder, within 30 days following the
end of each calendar quarter while any portion of this Note remains outstanding, a written statement signed by an authorized officer
of the Company certifying (i) the amount of the outstanding Principal balance of this Note, including any Interest added to Principal
pursuant to Section 2(a) and 2(b) above, and (ii) all accrued but unpaid Interest on such outstanding Principal balance, and (iii)
all remaining scheduled payments of Interest through the Maturity Date, in each case as of the end of such calendar quarter. The
parties agree that the scheduled Interest payments through the Maturity Date as of the Issuance Date are reflected in Exhibit
II attached hereto (which schedule is based on the assumptions outlined therein) and that each such quarterly statement delivered
by the Company under this Section 10(b) shall update such schedule to take into account any conversions, Events of Default, Major
Events or other events.

(c)Waiver
of Usury Defense. The Company covenants (to the extent that it may lawfully do so) that it shall not assert, plead (as
a defense or otherwise) or in any manner whatsoever claim (and shall actively resist any attempt to compel it to assert, plead
or claim) in any action, suit or proceeding that the interest rate on this Note violates present or future usury or other laws
relating to the interest payable on any Indebtedness and shall not otherwise avail itself (and shall actively resist any attempt
to compel it to avail itself) of the benefits or advantages of any such laws.

 

    	 

    	 

    

 

(d)Registration
Rights. The Company agrees that the Holder, as a holder of Registrable Securities (as defined in the Registration Rights Agreement,
dated as of April 21, 2011, by and among the Company and the Investors identified therein, as may be amended and/or restated from
time to time (the “Registration Rights Agreement”)), is entitled to the benefits of the Registration Rights
Agreement. Further, if (i) the Registration Statement (as defined in Registration Rights Agreement) required by Section 2(a) of
the Registration Rights Agreement, covering the Registrable Securities required to be covered thereby is (A) not filed with the
SEC on or before thirty (30) calendar days after the applicable Registration Request (as defined in Registration Rights Agreement)
(a “Filing Failure”) or (B) not declared effective by the SEC on or before the date that is one hundred and
eighty (180) calendar days after the applicable Registration Request, in each case to the extent required under the Registration
Rights Agreement (an “Effectiveness Failure”) or (ii) after the effective date of any Registration Statement,
after the second (2nd) consecutive Business Day (other than during an allowable blackout period pursuant to Section 3(g) of the
Registration Rights Agreement (“Blackout Period”)) on which sales of all of the Registrable Securities required
to be included on such Registration Statement cannot be made pursuant to such Registration Statement (including, without limitation,
because of a failure to keep such Registration Statement effective, to disclose such information as is necessary for sales to
be made pursuant to such Registration Statement, or to maintain a listing of the Common Stock required for sales to be made under
the Registration Statement) (a “Maintenance Failure”), then, as relief for the damages to the Holder by reason
of any such delay in or reduction of its ability to sell the Registrable Securities, the Company shall pay to the Holder an amount
in cash equal to (A) one percent (1%) of the outstanding Principal balance of this Note on each of the following dates: (i) the
day of a Filing Failure; (ii) the day of an Effectiveness Failure; and (iii) the initial day of a Maintenance Failure, and (B)
one percent (1%) of the outstanding Principal balance of this Note on each of the following dates: (i) on every thirtieth (30th)
day after the initial day of a Filing Failure (prorated for periods totaling less than thirty (30) days) until such Filing Failure
is cured; (ii) on every thirtieth (30th) day after the initial day of an Effectiveness Failure (prorated for periods totaling
less than thirty (30) days) until such Effectiveness Failure is cured; (iii) on every thirtieth (30th) day after the initial day
of a Maintenance Failure (prorated for periods totaling less than thirty (30) days) until such Maintenance Failure is cured. The
payments to which the Holder shall be entitled pursuant to this Section 10(d) are referred to herein as “Registration
Default Payments.” Registration Default Payments shall be paid on the earlier of (I) the last day of the calendar month
during which such Registration Default Payments are incurred and (II) the third (3rd) Business Day after the event or failure
giving rise to the Registration Default Payments is cured. In the event the Company fails to make Registration Default Payments
in a timely manner, such Registration Default Payments shall bear interest at the rate of one and one-half percent (1.5%)
per month (prorated for partial months) until paid in full. If the Company has declared a Blackout Period, a Maintenance Failure
shall be deemed not to have occurred and be continuing in relation to the Registration Statement during the period specified in
Section 3(g) of the Registration Rights Agreement. Registration Default Payments shall be payable from the first day any Blackout
Period exceeds the period specified in Section 3(g) of the Registration Rights Agreement. Registration Default Payments shall
cease to accrue at the end of the Effectiveness Period (as defined in Registration Rights Agreement); provided that the
foregoing shall not affect the Company’s obligation to make Registration Default Payments for any period prior to such time.
Whenever in this Note there is mentioned, in any context, the payment of interest on, or in respect of, this Note, such mention
shall be deemed to include mention of the payment of liquidated damages on this Note to the extent that, in such context, such
liquidated damages are, were or would be payable in respect thereof pursuant to this Section 10(d). For the avoidance of doubt,
the Registrable Securities required to be included in any Registration Statement referred to in this Section 10(d) shall be determined
according to the provisions of the Registration Rights Agreement, including all references to exceptions therein in such provisions
related to the “Rule 415 Amount,” as applicable.

(11)VOTE
TO ISSUE, OR CHANGE THE TERMS OF, NOTE. Any provision of this Note may be amended, waived or modified only upon the written
consent of both the Company and the Majority November 2014 Investors; provided, that no amendment or waiver may (a) extend
the Maturity Date of this Note, (b) decrease the Conversion Price or Conversion Rate of this Note, (c) reduce the rate or extend
the time for payment of any Interest on this Note, or (d) reduce the percentage of Notes required for consent to any modifications
of the Notes, without the consent of the Holder of this Note.

 

    	 

    	 

    

 

(12)TRANSFER.
This Note and the shares of Common Stock issuable upon conversion of this Note may not be offered for sale, sold, transferred
or assigned (i) in the absence of (a) an effective registration statement for this Note or the shares of Common Stock issuable
upon conversion of this Note, as applicable, or (b) an opinion of counsel (selected by the Holder and reasonably acceptable to
the Company), in a form reasonable acceptable to the Company, that this Note and the shares of Common Stock issuable upon conversion
of this Note may be offered for sale, sold, assigned or transferred pursuant to an exemption from registration; provided
that such opinion of counsel shall not be required in connection with any such sale, assignment or transfer to an institutional
accredited investor that is, prior to such sale, assignment or transfer, an affiliate of the Holder, or (ii) unless
the Holder provides the Company with assurance (reasonably satisfactory to the Company) that such Note or the shares of Common
Stock issuable upon the conversion of this Note can be sold, assigned or transferred pursuant to Rule 144.

(13)REISSUANCE
OF THIS NOTE.

(a)Transfer.
This Note is issued in registered form pursuant to Treasury Regulations section 1.871-14(c)(1). The Company (or its agent) will
maintain a record of the Holder of this Note, and of Principal and Interest hereon as required by that regulation. This Note may
be transferred or otherwise assigned only by surrender of this Note and issuance of a new Note in accordance with this Section
13, and neither this Note nor any interest herein may be sold, transferred or assigned to any Person except upon satisfaction
of the conditions specified in this Section 13. If this Note is to be transferred or assigned, the Holder shall surrender this
Note to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note (in accordance
with Section 13(d)), registered as the Holder may request, representing the outstanding Principal being transferred by the Holder
and, if less than the entire outstanding Principal is being transferred, a new Note (in accordance with Section 13(d)) to the
Holder representing the outstanding Principal not being transferred. The Holder and any assignee, by acceptance of this Note,
acknowledge and agree that, by reason of the provisions of Section 3(c)(iii) following conversion of any portion of this Note,
the outstanding Principal represented by this Note may be less than the Principal stated on the face of this Note.

(b)Lost,
Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by
the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the
Company shall execute and deliver to the Holder a new Note (in accordance with Section 13(d)) representing the then outstanding
Principal.

(c)Note
Exchangeable for Different Denominations. This Note is exchangeable, upon the surrender hereof by the Holder at the principal
office of the Company, for a new Note or Notes (in accordance with Section 13(d) and in Principal amounts of at least $100,000)
representing in the aggregate the outstanding Principal of this Note, and each such new Note will represent such portion of such
outstanding Principal as is designated by the Holder at the time of such surrender.

 

    	 

    	 

    

 

(d)Issuance
of New Notes. Whenever the Company is required to issue a new Note pursuant to the terms of this Note, such new Note (i) shall
be of like tenor with this Note, (ii) shall represent, as indicated on the face of such new Note, the Principal remaining outstanding
(or in the case of a new Note being issued pursuant to Section 13(a) or Section 13(c), the Principal designated by the Holder
which, when added to the principal represented by the other new Notes issued in connection with such issuance, does not exceed
the Principal remaining outstanding under this Note immediately prior to such issuance of new Notes), (iii) shall have an
issuance date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall have
the same rights and conditions as this Note, and (v) shall represent accrued Interest and Late Charges on the Principal and
Interest of this Note, from the Issuance Date.

(14)REMEDIES,
CHARACTERIZATIONS, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Note shall be cumulative
and in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity
(including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder’s
right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Note. Amounts
set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the
amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of
the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees
that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security
being required.

(15)PAYMENT
OF COLLECTION, ENFORCEMENT AND OTHER COSTS. If (a) this Note is placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding or the Holder otherwise takes action to collect amounts due under this
Note or to enforce the provisions of this Note or (b) there occurs any bankruptcy, reorganization, receivership of the Company
or other proceedings affecting Company creditors’ rights and involving a claim under this Note, then the Company shall pay
the costs incurred by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization,
receivership or other proceeding, including, but not limited to, reasonable attorneys’ fees and disbursements.

(16)CONSTRUCTION;
HEADINGS. This Note shall be deemed to be jointly drafted by the Company and the Holder of this Note and shall not be construed
against any person as the drafter hereof. The headings of this Note are for convenience of reference and shall not form part of,
or affect the interpretation of, this Note.

(17)FAILURE
OR INDULGENCE NOT WAIVER. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other
or further exercise thereof or of any other right, power or privilege.

 

    	 

    	 

    

 

(18)DISPUTE
RESOLUTION. In the case of a dispute as to the arithmetic calculation of the Conversion Rate, the Company shall submit the
disputed arithmetic calculations via facsimile within three (3) Business Days of receipt, or deemed receipt, of the Conversion
Notice, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such calculation within five
(5) Business Days of such disputed arithmetic calculation being submitted to the Holder, then the Company shall, within one Business
Day submit via facsimile the disputed arithmetic calculation of the Conversion Rate to the Company’s independent, outside
accountant. The Company, at the Company’s expense, shall cause the accountant, as the case may be, to perform the calculations
and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed
calculations. Such accountant’s calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

(19)NOTICES;
PAYMENTS.

(a)Notices.
Whenever notice is required to be given under this Note, unless otherwise provided herein, such notice shall be given in accordance
with the Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to
this Note, including in reasonable detail a description of such action and the reason therefor. Without limiting the generality
of the foregoing, the Company will give written notice to the Holder of any adjustment of the Conversion Price, setting forth
in reasonable detail, and certifying, the calculation of such adjustment.

(b)Payments.
Whenever any payment of cash is to be made by the Company to any Person pursuant to this Note, such payment shall be made in lawful
money of the United States of America by a check drawn on the account of the Company and sent via overnight courier service to
such Person at such address as previously provided to the Company in writing (which address, in the case of each of the initial
Holder of this Note, shall initially be as set forth on the signature page to the Purchase Agreement); provided that the Holder
may elect to receive a payment of cash via wire transfer of immediately available funds by providing the Company with prior written
notice setting out such request and the Holder’s wire transfer instructions. Whenever any amount expressed to be due by
the terms of this Note is due on any day which is not a Business Day, the same shall instead be due on the next succeeding day
which is a Business Day. Any amount of Principal or other amounts due under the this Note or the Transaction Documents, other
than Interest, which is not paid when due shall result in a late charge being incurred and payable by the Company in an amount
equal to interest on such amount at the rate of five percent (5%) per annum from the date such amount was due until the same is
paid in full (“Late Charge”).

(20)CANCELLATION.
After all Principal, accrued Interest and other amounts at any time owed on this Note have been paid in full, this Note shall
automatically be deemed canceled, shall be surrendered to the Company for cancellation and shall not be reissued.

(21)WAIVER
OF NOTICE. To the extent permitted by law, the Company hereby waives demand, notice, presentment, protest and all other demands
and notices (other than the notices expressly provided for in this Note) in connection with the delivery, acceptance, default
or enforcement of this Note and the Purchase Agreement.

 

    	 

    	 

    

 

(22)GOVERNING
LAW. This Note shall be construed and enforced in accordance with, and all questions concerning the construction, validity,
interpretation and performance of this Note shall be governed by, the internal laws of the State of New York, without giving effect
to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York.

(23)CERTAIN
DEFINITIONS. For purposes of this Note, the following terms shall have the following meanings:

(a)[Intentionally
omitted.]

(b)“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.

(c)“Change
of Control” means the consummation of any transaction described in clauses (i) through (v) of the definition of “Major
Event” in Section 2(d)(i).

(d)“Closing
Sale Price” means, as of any date, the last closing trade price for the Common Stock on the Eligible Market representing
the principal securities exchange or trading market for the Common Stock, as reported by Bloomberg, or, if such Eligible Market
begins to operate on an extended hours basis and does not designate the closing trade price, then the last trade price of such
security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no Eligible Market is the principal securities
exchange or trading market for the Common Stock, the last closing trade price of such security on the principal securities exchange
or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last
trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by
Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any market
makers for such security as reported in the “pink sheets” by OTC Markets Group, Inc. or any successor thereto. If
the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale
Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.

(e)“Common
Stock” means the shares of the Company’s common stock, par value $0.001 per share, and any other securities
of the Company which may be issued or issuable with respect to, in exchange for, or in substitution of, such shares of common
stock (including without limitation, by way of recapitalization, reclassification, reorganization, merger or otherwise).

(f)“Contingent
Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with
respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person
incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability
will be protected (in whole or in part) against loss with respect thereto.

 

    	 

    	 

    

 

(g)“Convertible
Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable
or exchangeable for Common Stock.

(h)“Eligible
Market” means The New York Stock Exchange (NYSE), the NYSE MKT, or The Nasdaq Stock Market, or their successors.

(i)“Exchange
Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.

(j)“GAAP”
means United States generally accepted accounting principles, consistently applied, or successor conventions.

(k)“Indebtedness”
of any Person means, without duplication (a) all indebtedness for borrowed money, (b) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services including, without limitation, “capital leases” in accordance
with GAAP (other than trade payables entered into in the ordinary course of business), (c) all reimbursement or payment obligations
with respect to letters of credit, surety bonds and other similar instruments, (d) all obligations evidenced by notes, bonds,
debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property,
assets or businesses, (e) all indebtedness created or arising under any conditional sale or other title retention agreement, or
incurred as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even
though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession
or sale of such property), (f) all monetary obligations under any leasing or similar arrangement which, in connection with GAAP,
consistently applied for the periods covered thereby, is classified as a capital lease, (g) any amount raised by acceptance under
any acceptance credit facility, (h) receivables sold or discounted (other than within the framework of factoring, securitization
or similar transaction where recourse is only to such receivables or proceeds), (i) any derivative transaction, (j) any
counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary letter of credit or any other
instrument issued by a bank or financial institution (excluding commercial letters of credit issued in the ordinary course of
business), (k) all indebtedness referred to in clauses (a) through (j) above secured by (or for which the holder of such
Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest
or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by any Person, even though
the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (l) all
Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (a) through (k)
above.

(l)“Options”
means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities.

 

    	 

    	 

    

 

(m)“Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

(n)“Reclassification”
means any reclassification or change of shares of Common Stock issuable upon conversion of this Note (other than a change in par
value, or from par value to no par value, or from no par value to par value, or as a result of a subdivision or combination).

(o)“Rule
144” means Rule 144 promulgated under the Securities Act and any successor provision thereto.

(p)“SEC”
means the United States Securities and Exchange Commission.

(q)“Securities
Act” means the Securities Act of 1933, as amended.

(r)“Subsidiary”
means with respect to any Person, any corporation, association or other business entity of which 50% or more of the total voting
power of equity entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers
or trustees or other governing body thereof is at the time owned or controlled by such Person (regardless of whether such equity
is owned directly or through one or more other Subsidiaries of such Person or a combination thereof).

(s)“Successor
Entity” means the Person, which may be the Company, formed by, resulting from or surviving any Change of Control or
the person with which such Change of Control transaction shall have been made. In the event that the Person resulting from or
surviving any Change of Control is a Subsidiary, Successor Entity shall be the parent of such Subsidiary.

(t)“Transaction
Documents” has the meaning given to such term in the Purchase Agreement.

IN
WITNESS WHEREOF, the Company has caused this Note to be duly executed as of the Issuance Date set out above.

 

		CareView Communications, Inc.
	 	 
		By:_________________________________
		     Name: Steven G. Johnson
		     Title: President

 

 

    	 

    	 

    

EXHIBIT I

CAREVIEW COMMUNICATIONS, INC.

CONVERSION NOTICE

 

Reference is made to the Convertible Note (the
“Note”) issued to the undersigned by CareView Communications, Inc. (the “Company”). In accordance
with and pursuant to the Note, the undersigned hereby elects to convert the Conversion Amount (as defined in the Note) of the Note
indicated below into shares of Common Stock par value $0.001 per share (the “Common Stock”) of the Company,
as of the date specified below.

 

	 Date of Conversion:	 

 

	Aggregate Conversion Amount to be converted:	 

 

	Please confirm the following information:

 

	Conversion Price:	 

 

	Number of shares of Common Stock to be issued:	 

 

	Please issue the Common Stock into which the Note is being converted in the following name and to the following address:

 

	Issue to:	 
	 	 
	 	 

 

	Facsimile Number:	 

 

	Authorization:	 

 

	By:	 

 

	Title:	 

 

	Dated:	 

 

	Account Number:	 
	(if electronic book entry transfer)

 

	Transaction Code Number:	 
	(if electronic book entry transfer)

 

 

    	 

    	 

    

 

 

Exhibit
II

 

Schedule
OF Interest Payments as of Issuance Date

 

See attached.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00238-of-00352.parquet"}]]